27 August 2015 – Early and accurate diagnosis of malaria is essential to appropriately target treatment and guide management of febrile illnesses. Access to rapid diagnostic tests (RDTs), one of the two WHO-recommended methods for testing suspected malaria cases, is increasing worldwide. Between 2008 and 2013, the volume of RDT sales in endemic countries rose from 46 to 319 million, making the production and selection of high-quality RDT a critical process. This new section provides guidance for organizations and individuals considering the use of RDTs, as well as for malaria control programmes, health services and test kit manufacturers.
WHO commends RBM Partnership’s contribution to global progress as governing board disbands secretariat
25 August 2015 – The Roll Back Malaria (RBM) Partnership, established in 1998 as part of a global drive to galvanize stronger action to curb malaria, is to restructure to meet the new challenges posed in the post-2015 era whilst building on the success of the last 17 years. In light of this restructuring and continued financial difficulties, the governing board has recommended disbanding the current RBM secretariat hosted by WHO in Geneva.
29 July 2015 – At a global meeting in New Delhi, WHO released today a new document which describes strategies aimed at controlling and eliminating Plasmodium vivax, the cause of an estimated 16 million malaria cases worldwide in 2013. The technical brief covers several key strategic areas: diagnostic testing and treatment of P. vivax infections, G6PD deficiency and radical cure with primaquine, and surveillance. Organized with the support of Medicines for Malaria Venture, the meeting shines a spot-light on the importance of tackling P. vivax to achieve elimination targets in the Global Technical Strategy for Malaria 2016–2030.